CorMedix Inc.CRMDNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank97
5Y CAGR+61.3%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+61.3%/yr
Long-term compound
Percentile
P97
Near historical high
vs 5Y Ago
10.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 206.13% |
| Q3 2025 | 2.88% |
| Q2 2025 | 51.96% |
| Q1 2025 | 451.53% |
| Q4 2024 | 58.87% |
| Q3 2024 | 2.78% |
| Q2 2024 | 18.89% |
| Q1 2024 | -61.09% |
| Q4 2023 | -23.55% |
| Q3 2023 | -1.46% |
| Q2 2023 | 17.52% |
| Q1 2023 | -68.87% |
| Q4 2022 | -2.66% |
| Q3 2022 | -9.76% |
| Q2 2022 | 19.01% |
| Q1 2022 | -14.91% |
| Q4 2021 | -6.65% |
| Q3 2021 | -78.02% |
| Q2 2021 | 53.79% |
| Q1 2021 | -12.76% |
| Q4 2020 | 18.86% |
| Q3 2020 | -869.40% |
| Q2 2020 | 90.53% |
| Q1 2020 | -105.08% |
| Q4 2019 | 2.01% |
| Q3 2019 | -2510.57% |
| Q2 2019 | 102.23% |
| Q1 2019 | -2.32% |
| Q4 2018 | -40.89% |
| Q3 2018 | -17.88% |
| Q2 2018 | 38.54% |
| Q1 2018 | 3.06% |
| Q4 2017 | -7.02% |
| Q3 2017 | 12.27% |
| Q2 2017 | -14.68% |
| Q1 2017 | -4.01% |
| Q4 2016 | 0.78% |
| Q3 2016 | -73.83% |
| Q2 2016 | 30.88% |
| Q1 2016 | -49.95% |